Functional and molecular evidence for expression of the renin angiotensin system and ADAM17-mediated ACE2 shedding in

Nadja Grobe1, Mauricio Di Fulvio1, Nada Kashkari1

  • 1Department of Pharmacology and Toxicology, Wright State University Boonshoft School of Medicine, Dayton, Ohio.

Insights

This study demonstrates the renin-angiotensin system (RAS) and ADAM17 are present and functional in COS7 cells. These findings highlight COS7 cells as a valuable model for studying angiotensin converting enzyme-2 (ACE2) shedding.

Area of Science:

  • Cardiovascular Biology
  • Renal Physiology
  • Cellular Signaling

Background:

  • The renin-angiotensin system (RAS) is crucial for cardiovascular and renal function.
  • COS7 cells, derived from African green monkey kidney, are widely used and easily transfected.
  • Understanding RAS components and their regulation in cell models is vital.

Purpose of the Study:

  • To confirm the presence and functionality of an endogenous RAS in COS7 cells.
  • To investigate the role of ADAM17 in the ectodomain shedding of ACE2.
  • To establish COS7 cells as a model for studying renal RAS and ACE2 shedding.

Main Methods:

  • Reverse transcription PCR for gene expression analysis.
  • Western blot and immunohistochemistry for protein identification.
  • Mass spectrometry to detect enzyme activities and peptide formation.
  • Stable transfection with shRNA to inhibit ADAM17.

Main Results:

  • Transcriptional evidence for ACE, ACE2, AT1R, and renin in COS7 cells.
  • Proteins ACE, ACE2, AT1R, renin, and ADAM17 were detected via Western blot and immunohistochemistry.
  • Endogenous renin, ACE, and ACE2 activities were confirmed using mass spectrometry.
  • ANG-(1-7) formation from ANG II was observed in cell lysates and media.
  • Inhibition of ADAM17 reduced ACE2 shedding into the media.

Conclusions:

  • COS7 cells express and exhibit functional endogenous RAS components.
  • ADAM17 mediates the ectodomain shedding of ACE2 in COS7 cells.
  • COS7 cells provide a robust and transfectable in vitro model for studying renal RAS and ACE2 shedding.

Related Concept Videos

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.9K
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
37.4K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.9K
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
4.6K
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
3.1K